New atherogenic indices: Assessment of cardio vascular risk in post menopausal dyslipidemia

Atherogenic Dyslipidemia and Residual Vascular Risk in Practice of Family Doctor

OBJECTIVE Timely recognition and optimal management of atherogenic dyslipidemia (AD) and residual vascular risk (RVR) in family medicine. BACKGROUND The global increase of the incidence of obesity is accompanied by an increase in the incidence of many metabolic and lipoprotein disorders, in particular AD, as an typical feature of obesity, metabolic syndrome, insulin resistance and diabetes ty...

Coronary Artery Disease (cad) Risk Factors and Cardio-respiratory Fitness in Pre and Post-menopausal Women

Atherogenic Dyslipidemia and Cardiovascular Risk Factors in Obese Children

Childhood obesity when associated with serum lipoprotein changes triggers atherosclerosis. Evidences suggest that the atherosclerotic process begins in childhood and that the extent of early atherosclerosis of the aorta and coronary arteries can be associated with lipoprotein levels and obesity. Furthermore, many studies in childhood demonstrate an important relationship between parameters of i...

Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients.

BACKGROUND AND PURPOSE Treatment with statins reduces the rate of cardiovascular events in high-risk patients, but residual risk persists. At least part of that risk may be attributable to atherogenic dyslipidemia characterized by low high-density lipoprotein cholesterol (≤40 mg/dL) and high triglycerides (triglycerides≥150 mg/dL). METHODS We studied subjects with stroke or transient ischemic...

Role of Antioxidants in Prevention of Cardio-Vascular Diseases

Coronary heart diseases are the most preventable non-contagious diseases, but unfortunately, ‎it is one of the major causes of mortality among humans in the industrialized and semi-‎industrialized countries. It is predicted that if this trend continues, it will lead to the death of ‎approximately over ‎‏25‏‎ million people in the world by ‎‏2020‏‎. On...